These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2824259)

  • 1. Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus.
    Bigley NJ; Blay RA; Smith RA
    Diabetes; 1987 Dec; 36(12):1408-13. PubMed ID: 2824259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D).
    McFarland HI; Bigley NJ
    Viral Immunol; 1989; 2(3):205-14. PubMed ID: 2560916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice.
    White LL; Smith RA
    Viral Immunol; 1990; 3(1):67-76. PubMed ID: 2153386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone modulation of interferon (IFN) alpha/beta and gamma production by mouse spleen cell subsets following picornavirus infection.
    Ishikawa R; Bigley NJ
    Viral Immunol; 1990; 3(3):225-36. PubMed ID: 2175195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
    Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the gender difference in interferon production seen in picornavirus-infected spleen cell cultures from ICR Swiss mice have any in vivo significance?
    Curiel RE; Miller MH; Ishikawa R; Thomas DC; Bigley NJ
    J Interferon Res; 1993 Dec; 13(6):387-95. PubMed ID: 7512115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropism and histopathology of the D, B, K, and MM variants of encephalomyocarditis virus.
    Cerutis DR; Bruner RH; Thomas DC; Giron DJ
    J Med Virol; 1989 Sep; 29(1):63-9. PubMed ID: 2555446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines produced early in picornavirus infection reflect resistance or susceptibility to disease.
    Curiel RE; Mason KM; Dryden TD; Maurer MJ; Bigley NJ
    J Interferon Cytokine Res; 1998 Aug; 18(8):587-96. PubMed ID: 9726440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference by a non-interferon-inducing subvariant of benign encephalomyocarditis virus-B with the ability of EMCV-D to produce insulin-dependent diabetes mellitus in ICR Swiss male mice.
    Giron DJ; Yei S
    J Interferon Res; 1993 Oct; 13(5):363-8. PubMed ID: 8301157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice.
    Gaines KL; Kayes SG; Wilson GL
    Diabetologia; 1987 Jun; 30(6):419-25. PubMed ID: 2824265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-induced murine diabetes. Enhancement by immunosuppression.
    Gould CL; McMannama KG; Bigley NJ; Giron DJ
    Diabetes; 1985 Dec; 34(12):1217-21. PubMed ID: 2998910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in mice by interferon.
    Gould CL; McMannama KG; Bigley NJ; Giron DJ
    J Interferon Res; 1985; 5(1):33-7. PubMed ID: 3886808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
    Kaptur PE; Thomas DC; Giron DJ
    Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
    Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
    Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tunicamycin enhances virus replication and inhibits antiviral activity of interferon in mice: correlation with natural killer cells.
    Singh VK; Damewood GP; Friedman RM; Maheshwari RK
    J Exp Pathol; 1987; 3(1):19-33. PubMed ID: 2445942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice.
    Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sex and early interferon production in the susceptibility of mice to encephalomyocarditis virus.
    Pozzetto B; Gresser I
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():701-9. PubMed ID: 2580047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice.
    Gaines KL; Kayes SG; Wilson GL
    Diabetologia; 1986 May; 29(5):313-20. PubMed ID: 3013707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephalomyocarditis virus and diabetes mellitus: studies on virus mutants in susceptible and non-susceptible mice.
    Kruppenbacher JP; Mertens T; Müntefering H; Eggers HJ
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():727-32. PubMed ID: 2984315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.